These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32441178)

  • 1. Methamphetamine Use and Its Correlates among Individuals with Opioid Use Disorder in a Midwestern U.S. City.
    Daniulaityte R; Silverstein SM; Crawford TN; Martins SS; Zule W; Zaragoza AJ; Carlson RG
    Subst Use Misuse; 2020; 55(11):1781-1789. PubMed ID: 32441178
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Silverstein SM; Daniulaityte R; Getz K; Zule W
    Subst Use Misuse; 2021; 56(11):1687-1696. PubMed ID: 34279180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis.
    Daniulaityte R; Nahhas RW; Silverstein S; Martins S; Zaragoza A; Moeller A; Carlson RG
    Drug Alcohol Depend; 2019 Nov; 204():107574. PubMed ID: 31568934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes and experiences with fentanyl contamination of methamphetamine: exploring self-reports and urine toxicology among persons who use methamphetamine and other drugs.
    Daniulaityte R; Ruhter L; Juhascik M; Silverstein S
    Harm Reduct J; 2023 Apr; 20(1):54. PubMed ID: 37081499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?
    Carlson RG; Daniulaityte R; Silverstein SM; Nahhas RW; Martins SS
    Int J Drug Policy; 2020 Apr; 79():102722. PubMed ID: 32311513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks.
    Daniulaityte R; Silverstein SM; Getz K; Juhascik M; McElhinny M; Dudley S
    Int J Drug Policy; 2022 Jan; 99():103463. PubMed ID: 34619443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys.
    Gerak LR; France CP
    J Pharmacol Exp Ther; 2023 Mar; 384(3):363-371. PubMed ID: 36575032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signals of increasing co-use of stimulants and opioids from online drug forum data.
    Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
    Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety.
    Saloner B; Whitley P; Dawson E; Passik S; Gordon AJ; Stein BD
    Addiction; 2023 Aug; 118(8):1549-1556. PubMed ID: 37158468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of nonfatal overdose among treatment-seeking individuals with non-heroin opioid use disorder: Findings from a pragmatic, pan-Canadian, randomized control trial.
    Crepeault H; Ti L; Jutras-Aswad D; Wood E; Le Foll B; Lim R; Bach P; Brar R; Socias ME
    J Subst Use Addict Treat; 2023 Dec; 155():209158. PubMed ID: 37683803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of transformations in supply on methamphetamine initiation among people injecting opioids in the United States.
    Mars S; Ondocsin J; Holm N; Ciccarone D
    Harm Reduct J; 2024 Mar; 21(1):57. PubMed ID: 38443903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and correlates of fentanyl preferences among people with opioid use disorder.
    Hochstatter KR; Terplan M; Mitchell SG; Schwartz RP; Dusek K; Wireman K; Gryczynski J
    Drug Alcohol Depend; 2022 Nov; 240():109630. PubMed ID: 36152404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl.
    Silverstein SM; Daniulaityte R; Martins SS; Miller SC; Carlson RG
    Int J Drug Policy; 2019 Dec; 74():76-83. PubMed ID: 31563098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trajectories of non-prescribed buprenorphine and other opioid use: A multi-trajectory latent class growth analysis.
    Daniulaityte R; Nahhas RW; Silverstein S; Martins S; Carlson RG
    J Subst Use Addict Treat; 2023 Apr; 147():208973. PubMed ID: 36804351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndemic factors associated with non-fatal overdose among young opioid users in New York City.
    Guarino H; Frank D; Quinn K; Kim D; Gile K; Ruggles K; Friedman SR; Mateu-Gelabert P
    Front Public Health; 2023; 11():1195657. PubMed ID: 37435512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State of the art treatment options for Pakistan's opioid, alcohol and methamphetamine crisis.
    Islam M
    J Pak Med Assoc; 2020 Jun; 70(6):1063-1068. PubMed ID: 32810107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medications for management of opioid use disorder.
    Koehl JL; Zimmerman DE; Bridgeman PJ
    Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine.
    Silverstein SM; Daniulaityte R; Miller SC; Martins SS; Carlson RG
    Drug Alcohol Depend; 2020 May; 210():107958. PubMed ID: 32203863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increases in methamphetamine injection among treatment admissions in the U.S.
    Jones CM; Han B; Seth P; Baldwin G; Compton WM
    Addict Behav; 2023 Jan; 136():107492. PubMed ID: 36156454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illicitly Manufactured Fentanyl Use Among Individuals in the U.S., 2022.
    Palamar JJ
    Am J Prev Med; 2024 Aug; 67(2):285-290. PubMed ID: 38527696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.